WOUND HEALING IN THE FETUS up to early third trimester of gestation is completely regenerative, proceeding in a scarless and nonfibrotic manner in contrast with wounds in adults (6, 9, 13, 20, 21, 30) . The reason for this difference is poorly understood, but there is evidence that the nature of fetal wound tissue and attributes of the cells, specifically fetal fibroblasts capacity for collagen contraction, is important. Interestingly, acute lung injury in extremely prematurely born human infants also rarely results in extensive pulmonary fibrosis, as commonly seen in adults recovering from such injury (12, 14) . Although this has been mostly attributed to differences in the stage of lung development, nature of the injury/injuring agent, and treatment interventions, the possibility that unique physicofunctional attributes of their lung fibroblasts may also be involved is yet to be fully explored. Understanding the cellular and molecular mechanisms governing this difference in outcomes remains a crucial area of investigation, with the ultimate goal of reducing the extent of fibrosis associated with wound healing.
One of the current hypotheses suggests that damage to the epithelium initiates the process of inflammation and repair by releasing soluble factors during necrosis and/or apoptosis triggering influx of inflammatory cells (11, 23, 27, 34) . Subsequent to the influx of neutrophils, granulocytes, and monocytes (and perhaps fibrocytes, epithelial cell precursors, and other circulating or even resident progenitor cells), the inflammatory response produces an increase in other soluble factors involved in the repair system that restores epithelial and endothelial integrity. During this stage of tissue remodeling following injury, the extent of recruitment of fibroblasts, their proliferation, and, finally, production of extracellular matrix components (primarily collagen) are partly responsible for the regeneration of normal tissue.
After extracellular matrix deposition, fibroblasts contract the new collagen matrix and undergo apoptosis. At the histological level, the healing early gestation fetal wound manifests a loose lattice of uncontracted connective tissue collagen fibers in contrast with the more abundant, contracted, and complex collagen network seen in adults. This has led to the idea that diminished cellular and molecular activation of collagen contraction may favor wound resolution with minimal fibrosis.
Although there are prior studies examining fibroblast ability for collagen contraction, none have compared fetal versus adult lung fibroblasts (24, 25) . Thus it is not known whether fibroblasts from fetal lungs compared with those from adult lungs differentially contract collagen. We were interested in determining whether lung fibroblasts from fetal or adult origin have comparable ability to contract a collagen matrix. Since a number of in vivo studies have identified the transforming growth factor-␤ (TGF-␤) signaling pathway as critical to the development of pulmonary fibrosis (5, 10) , analyzing the expression of components and targets of the TGF-␤ pathway and the nature of the extracellular matrix that fetal and adult lung fibroblasts produce was also of interest. In a broader approach, we studied their proteomes by two-dimensional electrophoresis to elucidate major differences that could potentially contribute to their different response to injury and the development of fibrosis.
MATERIALS AND METHODS
Detailed parameters and reagents used are provided in the online data supplement (all supplementary material can be found with the online version of this article).
Cells. Human lung fibroblasts from fetal or adult origin (batch numbers 1432, 1699, and 1865; Cell Applications, San Diego, CA) and IMR90 and CCD-8Lu cell lines (American Type Culture Collection) were all grown in DMEM supplemented with 10% FBS (Invitrogen) (37°C, 5% CO 2-95% room air) except for the CCD-8Lu cell line, which was grown in Eagle's minimum essential medium supplemented with 10% FBS. When comparisons were made, the same passage numbers (between 3 and 6) were used. Cells were routinely grown until 80% confluent and subcultured using 0.05% trypsin-0.01% EDTA (Lonza, Walkersville, MD) after rinsing with PBS.
Collagen contraction. Type I collagen gels were prepared by mixing cold rat tail HC collagen (BD Biosciences) with 10ϫ DMEM (Sigma-Aldrich, St. Louis, MO) on ice, neutralized with 1 M NaOH and diluted to 1 mg/ml collagen. Fibroblasts were trypsinized, resuspended in cold, serum-free DMEM, and added to the collagen mixture at a final concentration of 5 ϫ 10 5 cells/ml with 0.75 mg/ml as final collagen concentration. Aliquots (in triplicate) were cast onto 24-well plates and allowed to solidify at 37°C (30 -45 min), after which serum-free or 10% FBS-containing media was added, incubated, periodically observed for contraction, and photographed. Experiments were performed at least three times in each one of the human lung fibroblasts from fetal or adult cell lines.
GEArrays. Biotin-16-dUTP-labeled cDNA probes (GEArray; SuperArray, Bethesda, MD) were generated from 1 g total RNA templates. GEArray Q Series Human TGF-␤ bone morphogenetic protein (BMP) signaling pathway Gene Array (catalog number HS-023), Oligo GEArray human extracellular matrix, and adhesion molecules microarray (catalog number OHS-013) were used for analysis. The cDNA probes were denatured and hybridized with the GEArray membrane, washed, and exposed to a chemiluminescent substrate. Signal was detected with FluorChem detection system (Alpha Innotech, San Leandro, CA) and x-ray film. Background was subtracted with AlphaEase FC software of the imaging system. Signals were quantified and normalized to the ␤-actin housekeeping gene in each membrane.
Real-time PCR. cDNA was prepared using a first-strand cDNA synthesis kit (Invitrogen). Analysis was performed using the MyiQ single color real-time PCR detection system (Bio-Rad, Hercules, CA) with SYBR Green. Primers are provided in the online data supplement.
Two-dimensional gel electrophoresis and protein identification. Cell lysates for protein analysis were prepared as described by Keightley et al. (15) . Protein (500 g) was precipitated with acetone and resuspended in 180 l of 7 M urea, 2 M thiourea, 1% dithiothreitol, 1% ampholytes (Bio-Rad Biolytes 3/10), and 1% Triton X-100. Immobilized pH gradient strips (11-cm; pI 5-8 from Bio-Rad) were rehydrated. First dimension was run overnight, accumulating 60 kVh, and focused strips were then equilibrated, reduced, and alkylated in a buffer containing 6 M urea, 2% SDS, 20% glycerol, and either 100 mM dithiothreitol or 100 mM iodoacetamide. Equilibrated strips were immediately subjected to SDS-PAGE on a 10% criterion gel (BioRad). Gels were fixed, rinsed, and stained with Coomassie Blue (GelCode Blue; Pierce Biotechnology, Rockton, IL). After extensive rinsing, gels were visually examined for relative protein expression. A complete description of the method employed for protein identification is provided in the online data supplement.
Western blot analysis. Lysates from cells grown to 80% confluency were subjected to SDS-PAGE and Western blot using enhanced chemiluminescence (GE Healthcare Biosciences, Piscataway, NJ) as previously described (26) . Primary antibodies against smooth muscle actin (SMA), inhibin-␣ (Inh-␣), growth differentiation factor-5 (GDF-5), cell division cycle 25A (CDC25A), TGF-␤ receptor interacting protein-1 (TRIP-1), actin, and tubulin were used (antibody manufacturers are provided in the online data supplement).
TGF-␤ treatment. For TGF-␤ treatment, cells were grown to confluency in 60-mm dishes, starved in media in the absence of serum for 24 h, and then treated with 10 ng/ml TGF-␤ 1 for the times indicated and whole cell lysates were prepared and Western blot analysis was performed using an antibody against phosphorylated Smad3 (antibody manufacturer provided in the online data supplement).
Small interfering RNA-mediated TRIP-1 gene silencing studies. Silencer predesigned small interfering (si)RNA corresponding to the human sequence of TRIP-1 (catalog number AM16708, siRNA ID number 13735) and control siRNA-1 (catalog number AM 4611) were acquired (Ambion, Applied Biosystems, Austin, TX). Human lung fibroblasts from fetal grown in 100-mm dishes were transfected using Lipofectamine RNAiMAX (Invitrogen), according to manufacturer's instructions. Briefly, 225 l of Optimem containing 112, 225, and 450 pmol of siRNA were mixed with the same volume of Optimem, mixed with a solution containing 30 l of Lipofectamine RNAiMAX and 420 l Optimem, and allowed to incubate for 20 min at room temperature. After this incubation period, the lipid-siRNA complexes were added to plates containing 3.6 ml of Optimem (cells at 40% confluency). Transfection was allowed for 4 h, and media was then replaced with complete DMEM-FBS 10% growing media. Western blot from cells lysates and collagen gel contraction were performed 2 to 3 days after transfection.
RESULTS

Human lung fibroblasts from fetal or adult origin have different ability to contract a three-dimensional collagen matrix.
Using a type I collagen matrix contraction assay, we tested the ability of human lung fibroblasts from adult or fetal origin to contract the matrix. Two different fetal cell lines (gestation age, 16 to 20 wk) and three adult lines (45 to 48 yr old) were used. As shown in Fig. 1 , fetal cells contract the matrix to a significantly lesser extent than fibroblasts of adult origin. This result was observed regardless of which combination of fetal/ adult cell lines was used, or if assessed with cells at passage 3 versus passage 6. The same results are obtained if the assay is done in the absence of serum or in the presence of 10% FBS, although the process is faster in the presence of serum.
Analysis of smooth muscle actin expression in fetal and adult fibroblasts. ␣-SMA, expressed in myofibroblasts, could be responsible for the differential contraction ability of human lung fibroblasts from fetal and adult origin. To test this possibility, we analyzed the expression of SMA in both cell types and lines by Western blot. As seen in Fig. 2 , the expression level of SMA is very similar between fetal and adult cells and very low. Thus it cannot explain the differences seen in contraction ability.
Differential sensitivity of fetal and adult fibroblasts in culture to TGF-␤ treatment. In an attempt to address the role of TGF-␤ pathway activation in fetal versus adult lung fibroblasts, we analyzed the level of Smad3 as well as the response to TGF-␤ treatment in both cell types and lines (Fig. 3) . Surprisingly, we found that fetal lung fibroblasts respond quickly to activation by treatment with TGF-␤. In adult fibroblasts, treatment with TGF-␤ causes less phosphorylation. The activation of the Smad3-dependent pathway is not as robust in adult cells.
Analysis of TGF-␤ pathway components differentially expressed in fetal and adult fibroblasts. To elucidate possible differences between fetal and adult fibroblasts in the activation of the TGF-␤ pathway, we screened for a number of signaling components using the GEArray Q Series human TGF-␤ BMP signaling pathway gene array from SuperArray. This system allows for the simultaneous screening of 96 different genes that encode members of the TGF-␤ superfamily and key proteins involved in the TGF-␤ signal transduction pathway. Table 1 summarizes the results obtained for a set of fetal/adult samples hybridized in parallel to the membranes. Hybridization of the membranes with samples prepared from human lung fibroblasts of fetal or adult demonstrated a similar pattern of RNA expression for most of the targets present in the array, including ligands (TGF-␤ isoforms, BMPs, and activins), receptors, and Smads (from 1 to 9). There were significant differences in the mRNA level for some components of the TGF-␤ signaling pathway in both cell types; a higher level was observed for Inh-␣ (11-fold), GDF-5 (8-fold), Smad9 (2-fold), and the TGF-␤/activin responsive gene CDC25A (3.5-fold) in fetal fibroblasts, suggesting the possibility of an increased level of activation of the TGF-␤ pathway in these cells. As seen in Fig. 4 , A and C, these results were confirmed with real-time PCR analysis and Western blot analysis of the human lung fibroblast cell lines, with Inh-␣, GDF-5, and CDC25A expression higher in fetal cells compared with adult cells.
Differential expression of extracellular matrix components in fetal and adult lung fibroblasts. To gain insight into the possible differences in extracellular matrix components expression, a series of experiments were conducted using the Oligo GEArray human extracellular matrix and adhesion molecules microarray, which allows for the screening of the expression of 113 genes coding for extracellular matrix and adhesion molecules. Tables 2 and 3 summarize the results of the analysis. Collagen IV ␣ 2 was more abundant in fetal cells (6 times higher), whereas laminin ␣ 4 and thrombospondin were more abundant in adult cells (almost 5-fold). Interestingly, tissue inhibitor of metalloproteinases 3 (TIMP-3) RNA was undetectable in fetal cells, and matrix metalloproteinase-2 (MMP-2) RNA levels were also higher in adult cells (2-fold). These results were confirmed by real-time PCR analysis (Fig. 4B ) and found to be significantly different in all cases except for Collagen IV ␣ 2 , which, although higher in fetal relative to adult cells, was not statistically different. The mRNA levels for most of the integrins were low, but we confirmed that ␣ 2 -, ␣ 3 -, ␤ 1 -, and ␤ 5 -integrins were similar in both cell types (data not shown).
Proteomic analysis of fetal and adult lung fibroblasts. To gain insight into major differences in the cell proteome of fetal and adult lung fibroblasts, we performed two-dimensional gel electrophoresis followed by Coomassie staining. As shown in Fig. 5 , the fraction of the total proteome resolved under these conditions presented a very similar pattern, but a number of proteins were identified as clearly differentially expressed in both cell types. Twenty-two spots were selected and processed, as described in METHODS of the online data supplement, and submitted to liquid chromatography-mass spectrometry for protein identification, always from the gel where the protein appeared to be more abundant. Table 4 lists the overall iden- tifications, and a list of the individual peptides identified for each spot can be found in Table E .1 of the online data supplement. Included in the identifications are ribosomal proteins and enzymes, but more interestingly, we found annexin I, II, and VII as well as small GTPases cdc42 and RhoA and signaling proteins like TRIP-1 and LIM and SH3 domain protein 1 (LASP1) differentially expressed based on the analysis. Proteomic analysis identified TRIP-1 expression was significantly lower in adult cells compared with fetal.
TRIP-1 expression is higher in fetal versus adult lung fibroblasts. Due to the known role of TRIP-1 as regulator of TGF-␤ signaling, we wanted to confirm the result obtained in the proteomic analysis by Western blot for TRIP-1 in cell lysates. Shown in Fig. 6A is an enlarged region of the image shown in Fig. 5 for both cell types. In Fig. 6B , we observe that the expression of TRIP-1 is higher in cells of fetal origin than in adult cells. Similar results were obtained for the different fetal and adult fibroblast cell lines compared.
Determination of the effect of TRIP-1 on fibroblast collagen contraction. To determine whether TRIP-1 modulates fibroblast collagen contraction, we assessed collagen contraction in fetal cells after siRNA mediated silencing of TRIP-1 gene expression. As shown in Fig. 7 , siRNA knockdown of TRIP-1 gene expression in fetal fibroblasts significantly enhanced collagen contraction, indicating that TRIP-1 is a negative regulator of fibroblast collagen contraction. The higher level in fetal fibroblasts inhibits their collagen contraction response.
DISCUSSION
It is well established that skin wounds in the early gestation fetus heal without scar formation and fibrosis in contrast with similar wounds in adults (6, 9, 13, 20, 21, 30) . The histological phenotype of such wounds is shown to be composed of a loose array of uncontracted connective tissue collagen fibers, which may suggest fetal dermal fibroblasts have a reduced ability to contract the collagen matrix. Although there is paucity of data with respect to the lungs, anecdotal observations suggest that acute lung injury in very immature lungs such as of the extremely preterm-born human infant rarely results in extensive pulmonary fibrosis and contracture, as is often seen in adult lungs following such injury.
In the present study, we compared the collagen contraction ability of human fetal versus adult lung fibroblasts and probed the molecular mechanisms governing the observed difference. Our results show that human fetal lung fibroblasts are less effective at collagen contraction than fibroblasts from adult lungs. Moreover, proteomic analysis in conjunction with mRNA expression profiling targeted to components of the TGF-␤ signaling pathway and the extracellular matrix reveal differential expression of a number of biologically active molecules between the cell types. Of particular note is TRIP-1, which we identify is highly expressed in fetal relative to adult lung fibroblasts. We have uncovered that this protein is a negative regulator of fibroblast collagen contraction, such that the higher level in fetal fibroblasts inhibits their collagen contraction ability.
To our knowledge, this is the first report identifying TRIP-1 as an important modulator of fibroblast collagen contraction and implicating this protein in the differential ability of fetal fibroblasts to contract collagen, relative to fibroblasts from adults. The finding is important because it reveals a potential target for therapeutic or prophylactic manipulation to minimize wound healing-associated fibrosis.
Several factors including TGF-␤, PDGF, or serum treatment are known to independently increase collagen contraction by fibroblasts. In our experiments, we found that the difference in collagen contraction ability of fetal versus adult lung fibroblasts is evident both in the presence of or absence of serum, suggesting that intrinsic differences in their properties are involved. However, we also observed that in the presence of serum, there is acceleration in time to onset of contraction consistent with factors in the serum playing some role in this respect.
TGF-␤ promotes diverse functions that include regulation of cell growth, extracellular matrix remodeling, and fibrosis as may occur during wound healing. An important mechanism by which the ligand achieves some of its function is through interaction with its cell surface receptors to cause phosphorylation of the Smad group of intracellular signaling proteins 3 . Western blot analysis of transforming growth factor-␤ (TGF-␤) signaling. Cells grown to confluency were starved overnight and then treated with 10 ng/ml TGF-␤ for the times indicated. Lysates were prepared as described in MATERIALS AND METHODS. Experiments were repeated 3 times in each cell type, and blots correspond to HLF-F no. 1432 and HLF-A no. 1699. (22) . Binding of the TGF-␤ ligand to the type II receptor is believed to lead to recruitment, phosphorylation, and consequent activation of the type I receptor, which then directly phosphorylates Smads 2 and 3. Phosphorylated Smad2/3 associates with Smad4 to translocate into the nucleus where in interactions with coactivators or corepressors, it activates or suppresses target gene transcription.
The importance of TGF-␤-activated Smad3 signaling in collagen matrix contraction in vitro, and in vivo as reflected in the level of wound fibrosis, has been well demonstrated (2, 3, 18, 19, 32) . In human dermal (32) and mouse embryonic (18) fibroblasts, Smad3 was shown to be essential for collagen matrix contraction. In Smad3-null mice, accelerated/scarless wound healing (2, 3) is seen depending on the nature of the wound, and these mice do not develop pulmonary fibrosis when subjected to bleomycin lung injury.
Colwell et al. (8) showed there is a similar level of transcriptional regulation of Smad3 and Smad7 in fetal versus adult dermal fibroblasts following stimulation with TGF-␤, suggesting that lack of scarring in early gestation wounds is not due to a lack of response of fetal fibroblast to TGF-␤. In agreement with that observation, we did not detect a significant difference at the gene transcript level for these Smads between fetal and adult lung fibroblasts but, however, were surprised to find that fetal fibroblasts despite exhibiting a reduced ability for collagen contraction relative to adults have a more robust activation 1699. GDF-5, growth differentiation factor 5; Inh-␣ (Inh-A), ␣-inhibin; CDC25, cell division cycle 25A. B: real-time PCR analysis for selected mRNAs corresponding to extracellular matrix components. COL4-␣2 (COL4A2), collagen type IV, ␣2-subunit; TIMP-3, tissue inhibitor of metalloproteinase 3; MMP-2, matrix metalloproteinase 2; LAM-␣4 (LAMA4), laminin, type ␣4; THSB2: thrombospondin 2. White columns correspond to HLF-F, and gray columns correspond to HLF-A. P values correspond to differences in gene expression between adult samples compared with fetal samples. For each mRNA analyzed, relative target expression was calculated normalizing to ␤-actin levels in the same sample. Experimental values for fetal samples were then set to 1, and the normalized adult samples were compared with this value. Columns represent means for 3 samples, and error bars reflect SD. Statistical analysis was performed using Graphpad-Instat, applying paired t-test. *P Ͻ 0.05; **P Ͻ 0.005. C: Western blot analysis for Inh-␣, GDF-5, and CDC25A shown in the same cell types. Results shown are representative of four different samples prepared in parallel for fetal (batch no. 1432) and adult (batch no. 1699) cells at the same passage numbers. ND, not determined (undetectable in HLF-F).
(phosphorylation) of Smad3 in response to TGF-␤ stimulation. Smad7 is a regulatory Smad with inhibitory effects on TGF-␤ signaling, but we ascertained by Western blot (not shown) that its protein expression and that of Smad9, which was increased at the transcript level, was not different between the fibroblast cell types and so could not explain our findings.
TGF-␤ signaling, however, is also modulated by other factors such as TRIP-1 (7), which we now identify is highly expressed in fetal fibroblasts relative to adult lung fibroblasts. TRIP-1 has been shown to modulate TGF-␤-stimulated cellular response both in a TGF-␤ receptor and Smad dependent and in an independent manner (7). In the current study, we found that TRIP-1 inhibits fibroblast collagen contraction. The higher level in fetal fibroblasts, as we demonstrated, inhibits their collagen contraction response. Thus TRIP-1 could explain, at least in part, the differential collagen contraction ability of fetal relative to adult lung fibroblasts.
As reported in RESULTS, a number of other biologically active molecules were detected as differentially expressed between the cell types. Activins, inhibins, and GDF-5 participate in the TGF-␤ signaling system. Ohga et al. (28) described the presence of activin A receptors in human fetal lung fibroblasts and demonstrated the stimulation of collagen gel contraction by activin A in a dose-dependent manner. It was, therefore, encouraging to find, in our initial screening, a higher level in messenger RNA for Inh-␣, activin A, GDF-5, and their target gene CDC25A in fetal compared with adult cells and that these results were confirmed on real-time PCR analysis and on Western blot. This, together with the differential phosphorylation of Smad3 in response to TGF-␤ treatment we observed, suggests that the level of activation of the TGF-␤ pathway is different for both cell types.
Fibroblasts rely on integrin receptors to link their force generating actin cytoskeletal assembly to the collagen matrix, and this is crucial for collagen contraction. As mentioned in RESULTS, we did not detect a significant difference in the level of expression of ␣ 1 -, ␣ 2 -, ␣ 3 -, and ␤ 1 -integrins between the fetal and adult human lung fibroblasts. This is contrary with findings in dermal fibroblasts by Moulin and Plamondon (24) in their study. Perhaps this is due to differences in the fibroblast types or could also be due to differences in methods. It is also known that fibroblasts may differentiate into myofibroblasts, conferring a more contractile phenotype by virtue of acquisition of ␣-SMA, a powerful cytoskeletal contractile protein.
We, therefore, considered the possibility that this may account for the difference in collagen contraction ability observed between the fetal versus adult lung fibroblasts in this study. As we discerned, the difference could not be attributed to this since both cell types expressed equally low levels of this protein when cultured under identical conditions, as deter- Table 4 , and a complete list of the identified peptides can be found in the online data supplement (Table E1) . mined by Western blot. Thus the observed difference is not a consequence of the presence of more myofibroblasts in the adult fibroblast pool relative to the fetal fibroblast pool. Cytoskeletal rearrangement is a critical mediator in collagen contraction (29) . Results from our proteomic analysis point to a difference in the levels of small GTPases like Rho and cdc42, critical regulators of cytoskeletal reorganization required for cell motility between the fibroblast cell types in this study. Lakshman et al. (16) demonstrated a role for Rho kinase (ROCK) in matrix remodeling by corneal fibroblasts. Abe et al. (1) showed that activation of Rho and ROCK are required for increased collagen gel contraction by dermal fibroblasts in response to basic FGF. Importantly, Shimizu et al. (31) reported that Rho and its target ROCK contribute to lung fibrosis in the bleomycin mouse model and that a selective ROCK inhibitor can prevent development of fibrosis in this model. Another family of proteins that we found differentially expressed is the annexins. Babbin et al. (4) have reported that annexin II controls Rho activity in intestinal epithelial cells where it targets RhoA to cellular membranes during epithelial cell migration in a wounding model. Interestingly, our proteomic data show there is a higher annexin II expression in the adult lung fibroblasts compared with their fetal counterparts; this is despite similar levels of RhoA expressed by both fibroblast cell types as assessed under the same culture conditions (data not shown).
The nature of the extracellular matrix in fetal and adult tissue after injury may influence development of fibrosis (33) , and MMP acting in concert with their tissue inhibitors has been shown to be important. We found that fetal lung fibroblasts have a decreased level of TIMP-3 and MMP-2 expression compared with adult fibroblasts. Interestingly, in a model of TIMP-3 knockout mice, aged mice have reduced collagen content compared with same age controls (17) , suggesting that TIMP-3 expression in the normal adult lung contributes to increased collagen synthesis and deposition.
In summary, this study found that human fetal lung fibroblasts are less effective at collagen contraction than fibroblasts from adults. Stimulation of the cell types with TGF-␤, however, generates a more robust activation of TGF-␤ signaling in fetal compared with adult cells, as assessed by their level of Smad3 phosphorylation. A number of biologically active molecules are differentially expressed between the cell types as revealed by proteomic and mRNA profiling. Of note is TRIP-1, which we show inhibits fibroblast collagen contraction and is higher in fetal than adult fibroblasts. We conclude that the diminished ability of fetal fibroblasts for collagen contraction relative to adults is not due to inability to activate the TGF-␤ pathway but rather at least in part due to their higher level of TRIP-1 expression. TRIP-1 is a novel modulator of fibroblast collagen contraction. 
